These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Challenges, experiences, and postoperative outcomes in setting up first successful lung transplant unit in India. Rahulan V; Shah U; Yadav P; Ravipathy S; Jindal A; Suresh S; Sandeepa HS; Kumar P; Mohandas A; Kumar S; Shivanna S; Kori S; Dutta P; Anand P; Mahesh BN; Madhusudana N; Bhaskar BV; Balasubramani G; Attawar S Lung India; 2021; 38(3):216-222. PubMed ID: 33942744 [TBL] [Abstract][Full Text] [Related]
24. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD). Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284 [TBL] [Abstract][Full Text] [Related]
25. Donor Preconditioning with Inhaled Sevoflurane Mitigates the Effects of Ischemia-Reperfusion Injury in a Swine Model of Lung Transplantation. Bertani A; Miceli V; De Monte L; Occhipinti G; Pagano V; Liotta R; Badami E; Tuzzolino F; Arcadipane A Biomed Res Int; 2021; 2021():6625955. PubMed ID: 33506025 [TBL] [Abstract][Full Text] [Related]
26. Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review. Talaie T; DiChiacchio L; Prasad NK; Pasrija C; Julliard W; Kaczorowski DJ; Zhao Y; Lau CL Transplant Direct; 2021 Feb; 7(2):e652. PubMed ID: 33437867 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-206 antagomiR‒enriched extracellular vesicles attenuate lung ischemia‒reperfusion injury through CXCL1 regulation in alveolar epithelial cells. Cai J; Gehrau R; Tu Z; Leroy V; Su G; Shang J; Mas VR; Emtiazjoo A; Pelaez A; Atkinson C; Machuca T; Upchurch GR; Sharma AK J Heart Lung Transplant; 2020 Dec; 39(12):1476-1490. PubMed ID: 33067103 [TBL] [Abstract][Full Text] [Related]
28. Single versus double lung transplantation for fibrotic disease-systematic review. Wilson-Smith AR; Kim YS; Evans GE; Yan TD Ann Cardiothorac Surg; 2020 Jan; 9(1):10-19. PubMed ID: 32175235 [TBL] [Abstract][Full Text] [Related]
29. Role of donor macrophages after heart and lung transplantation. Kopecky BJ; Frye C; Terada Y; Balsara KR; Kreisel D; Lavine KJ Am J Transplant; 2020 May; 20(5):1225-1235. PubMed ID: 31850651 [TBL] [Abstract][Full Text] [Related]
30. Postoperative management of lung transplant recipients. Kao CC; Parulekar AD J Thorac Dis; 2019 Sep; 11(Suppl 14):S1782-S1788. PubMed ID: 31632755 [TBL] [Abstract][Full Text] [Related]
31. Early Graft Dysfunction after Lung Transplantation. Rosenheck J; Pietras C; Cantu E Curr Pulmonol Rep; 2018 Dec; 7(4):176-187. PubMed ID: 31548919 [TBL] [Abstract][Full Text] [Related]
32. The effect of primary graft dysfunction after lung transplantation on parenchymal remodeling detected by quantitative computed tomography. Salito C; Aliverti A; Tosi D; Pennati F; Carrinola R; Rosso L; Tarsia P; Morlacchi LC; Nosotti M; Palleschi A J Thorac Dis; 2019 Apr; 11(4):1213-1222. PubMed ID: 31179063 [TBL] [Abstract][Full Text] [Related]
33. Generation and persistence of human tissue-resident memory T cells in lung transplantation. Snyder ME; Finlayson MO; Connors TJ; Dogra P; Senda T; Bush E; Carpenter D; Marboe C; Benvenuto L; Shah L; Robbins H; Hook JL; Sykes M; D'Ovidio F; Bacchetta M; Sonett JR; Lederer DJ; Arcasoy S; Sims PA; Farber DL Sci Immunol; 2019 Mar; 4(33):. PubMed ID: 30850393 [TBL] [Abstract][Full Text] [Related]